Latest News and Press Releases

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company

Investors who lost money in DRVN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

PHILADELPHIA, May 04, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Gossamer Bio, Inc. (NASDAQ: GOSS) (“Gossamer” or the...

Investors who lost money in EOSE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Reel-Funding Group launches a multi-fund platform to finance independent films with filmmakers, building scalable production slates.

Raanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative...

VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol...

Showcasing AI Driven Approach to Physical Security and Expanding Market Reach Detroit, Michigan, May 04, 2026 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”)...

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm